Nasdaq-listed company Enlivex Therapeutics announced it has secured $21 million in debt financing from The Lind Partners, a New York-based institutional investment management firm. Enlivex stated it will continue advancing its RAIN token digital asset treasury strategy and plans to increase holdings of approximately 3 billion RAIN tokens. RAIN is a decentralized prediction market protocol running on the Arbitrum network. (The Block)

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin